YURY KRYVALAP, RIM HABTE, SHAWN Z. MENG, JAN CZYZYK
{"title":"1804-P: Beta-Cell Loss with Severe Hyperglycemia Is Responsible for Augmented Notch 1 Expression in the Pancreatic Exocrine Ductal Cells","authors":"YURY KRYVALAP, RIM HABTE, SHAWN Z. MENG, JAN CZYZYK","doi":"10.2337/db25-1804-p","DOIUrl":null,"url":null,"abstract":"Introduction and Objective: Functional crosstalk between pancreatic islets and exocrine pancreatic tissue may be a determining factor in the progression of type 1 diabetes (T1D). Supporting this premise, we found that inhibition of serpinB13, an inhibitor of cathepsin L (catL) proteinase expressed in the exocrine pancreatic ductal cells, has positive outcomes in T1D. We also found that cleavage of Notch1 (a gatekeeper of β-cell development) following inhibition of serpinB13 with a monoclonal antibody (mAb), is a key molecular event that connects endocrine and exocrine tissue in the pancreas. Based on our observations, we hypothesized that the Notch1 receptor is expressed in the pancreatic ductal tree. Methods: To examine this, we induced β-cell-specific ablation with diphtheria toxin (DT) in InsCre/Rosa26iDTR transgenic mice, which were treated with a wild-type islet transplant or left untreated and sacrificed for pancreatic examination 2 weeks after diabetes induction. To assess Notch1 in the pancreas we used Western blot and IF microscopy with the Visiopharm software. Results: Both methods revealed that severe insulin-dependent diabetes results in marked augmentation of Notch1 expression (p<0.0001 and p=0.0054, respectively). The marked increase in the Notch1 protein level was specific, as expression of presenilins (which are required for processing of Notch1) was intact. We also found that islet transplantation preventing hyperglycemia in DT-treated animals completely blocked Notch1 upregulation. Finally, histological analysis revealed that Notch1 expression is confined to the cytokeratin-19+ epithelial cells in the exocrine ducts. Conclusion: We conclude that high Notch1 expression in the exocrine pancreas may explain its regulation by serpinB13. Moreover, our results demonstarte that hyperglycemia, rather than direct sensing of β-cell loss by the exocrine pancreas, is responsible for Notch upregulation in ductal epithelium. Disclosure Y. Kryvalap: None. R. Habte: None. S.Z. Meng: None. J. Czyzyk: None.","PeriodicalId":11376,"journal":{"name":"Diabetes","volume":"517 1","pages":""},"PeriodicalIF":7.5000,"publicationDate":"2025-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2337/db25-1804-p","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction and Objective: Functional crosstalk between pancreatic islets and exocrine pancreatic tissue may be a determining factor in the progression of type 1 diabetes (T1D). Supporting this premise, we found that inhibition of serpinB13, an inhibitor of cathepsin L (catL) proteinase expressed in the exocrine pancreatic ductal cells, has positive outcomes in T1D. We also found that cleavage of Notch1 (a gatekeeper of β-cell development) following inhibition of serpinB13 with a monoclonal antibody (mAb), is a key molecular event that connects endocrine and exocrine tissue in the pancreas. Based on our observations, we hypothesized that the Notch1 receptor is expressed in the pancreatic ductal tree. Methods: To examine this, we induced β-cell-specific ablation with diphtheria toxin (DT) in InsCre/Rosa26iDTR transgenic mice, which were treated with a wild-type islet transplant or left untreated and sacrificed for pancreatic examination 2 weeks after diabetes induction. To assess Notch1 in the pancreas we used Western blot and IF microscopy with the Visiopharm software. Results: Both methods revealed that severe insulin-dependent diabetes results in marked augmentation of Notch1 expression (p<0.0001 and p=0.0054, respectively). The marked increase in the Notch1 protein level was specific, as expression of presenilins (which are required for processing of Notch1) was intact. We also found that islet transplantation preventing hyperglycemia in DT-treated animals completely blocked Notch1 upregulation. Finally, histological analysis revealed that Notch1 expression is confined to the cytokeratin-19+ epithelial cells in the exocrine ducts. Conclusion: We conclude that high Notch1 expression in the exocrine pancreas may explain its regulation by serpinB13. Moreover, our results demonstarte that hyperglycemia, rather than direct sensing of β-cell loss by the exocrine pancreas, is responsible for Notch upregulation in ductal epithelium. Disclosure Y. Kryvalap: None. R. Habte: None. S.Z. Meng: None. J. Czyzyk: None.
期刊介绍:
Diabetes is a scientific journal that publishes original research exploring the physiological and pathophysiological aspects of diabetes mellitus. We encourage submissions of manuscripts pertaining to laboratory, animal, or human research, covering a wide range of topics. Our primary focus is on investigative reports investigating various aspects such as the development and progression of diabetes, along with its associated complications. We also welcome studies delving into normal and pathological pancreatic islet function and intermediary metabolism, as well as exploring the mechanisms of drug and hormone action from a pharmacological perspective. Additionally, we encourage submissions that delve into the biochemical and molecular aspects of both normal and abnormal biological processes.
However, it is important to note that we do not publish studies relating to diabetes education or the application of accepted therapeutic and diagnostic approaches to patients with diabetes mellitus. Our aim is to provide a platform for research that contributes to advancing our understanding of the underlying mechanisms and processes of diabetes.